180 related articles for article (PubMed ID: 8555467)
1. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease.
Falini B; Bigerna B; Pasqualucci L; Fizzotti M; Martelli MF; Pileri S; Pinto A; Carbone A; Venturi S; Pacini R; Cattoretti G; Pescarmona E; Lo Coco F; Pelicci PG; Anagnastopoulos I; Dalla-Favera R; Flenghi L
Blood; 1996 Jan; 87(2):465-71. PubMed ID: 8555467
[TBL] [Abstract][Full Text] [Related]
2. Bcl-6 protein expression in normal and neoplastic lymphoid tissues.
Falini B; Fizzotti M; Pileri S; Liso A; Pasqualucci L; Flenghi L
Ann Oncol; 1997; 8 Suppl 2():101-4. PubMed ID: 9209651
[TBL] [Abstract][Full Text] [Related]
3. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease.
Carbone A; Gloghini A; Gaidano G; Franceschi S; Capello D; Drexler HG; Falini B; Dalla-Favera R
Blood; 1998 Oct; 92(7):2220-8. PubMed ID: 9746758
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells.
Carbone A; Gloghini A; Larocca LM; Antinori A; Falini B; Tirelli U; Dalla-Favera R; Gaidano G
Blood; 1999 Apr; 93(7):2319-26. PubMed ID: 10090942
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.
Flenghi L; Bigerna B; Fizzotti M; Venturi S; Pasqualucci L; Pileri S; Ye BH; Gambacorta M; Pacini R; Baroni CD; Pescarmona E; Anagnostopoulos I; Stein H; Asdrubali G; Martelli MF; Pelicci PG; Dalla-Favera R; Falini B
Am J Pathol; 1996 May; 148(5):1543-55. PubMed ID: 8623923
[TBL] [Abstract][Full Text] [Related]
6. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells.
Flenghi L; Ye BH; Fizzotti M; Bigerna B; Cattoretti G; Venturi S; Pacini R; Pileri S; Lo Coco F; Pescarmona E
Am J Pathol; 1995 Aug; 147(2):405-11. PubMed ID: 7639334
[TBL] [Abstract][Full Text] [Related]
7. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
8. BCL-6 protein is expressed in germinal-center B cells.
Cattoretti G; Chang CC; Cechova K; Zhang J; Ye BH; Falini B; Louie DC; Offit K; Chaganti RS; Dalla-Favera R
Blood; 1995 Jul; 86(1):45-53. PubMed ID: 7795255
[TBL] [Abstract][Full Text] [Related]
9. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.
Onizuka T; Moriyama M; Yamochi T; Kuroda T; Kazama A; Kanazawa N; Sato K; Kato T; Ota H; Mori S
Blood; 1995 Jul; 86(1):28-37. PubMed ID: 7795234
[TBL] [Abstract][Full Text] [Related]
10. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1.
Carbone A; Gloghini A; Gattei V; Degan M; Improta S; Aldinucci D; Canzonieri V; Perin T; Volpe R; Gaidano G; Zagonel V; Pinto A
Blood; 1997 May; 89(10):3787-94. PubMed ID: 9160685
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
[TBL] [Abstract][Full Text] [Related]
12. BCL-6 expression during B-cell activation.
Allman D; Jain A; Dent A; Maile RR; Selvaggi T; Kehry MR; Staudt LM
Blood; 1996 Jun; 87(12):5257-68. PubMed ID: 8652841
[TBL] [Abstract][Full Text] [Related]
13. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells.
Bargou RC; Leng C; Krappmann D; Emmerich F; Mapara MY; Bommert K; Royer HD; Scheidereit C; Dörken B
Blood; 1996 May; 87(10):4340-7. PubMed ID: 8639794
[TBL] [Abstract][Full Text] [Related]
14. Antiapoptotic marker Bcl-X(L), expression on Reed-Sternberg cells of Hodgkin's disease using a novel monoclonal marker, YTH-2H12.
Chu WS; Aguilera NS; Wei MQ; Abbondanzo SL
Hum Pathol; 1999 Sep; 30(9):1065-70. PubMed ID: 10492041
[TBL] [Abstract][Full Text] [Related]
15. Can Reed-Sternberg cells of classic Hodgkin's disease be considered B-cells?
Carbone A; Gloghini A; Gaidano G
Adv Clin Path; 1999; 3(1-2):3-9. PubMed ID: 10655568
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus and bcl-2 protein overexpression are not detected in the neoplastic cells of nodular lymphocyte predominance Hodgkin's disease.
Alkan S; Ross CW; Hanson CA; Schnitzer B
Mod Pathol; 1995 Jun; 8(5):544-7. PubMed ID: 7675775
[TBL] [Abstract][Full Text] [Related]
17. CD40 Ligand--an anti-apoptotic molecule in Hodgkin's disease.
Metkar SS; Manna PP; Anand M; Naresh KN; Advani SH; Nadkarni JJ
Cancer Biother Radiopharm; 2001 Feb; 16(1):85-92. PubMed ID: 11279801
[TBL] [Abstract][Full Text] [Related]
18. Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction.
Greiner TC; Gascoyne RD; Anderson ME; Kingma DW; Adomat SA; Said J; Jaffe ES
Blood; 1996 Jul; 88(2):657-66. PubMed ID: 8695813
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease.
Carbone A; Gloghini A; Aldinucci D; Gattei V; Dalla-Favera R; Gaidano G
Br J Haematol; 2002 May; 117(2):366-72. PubMed ID: 11972519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
